t
Accrol Group Holdings plc announced on 22 August 2023 that Executive Chairman Dan Wright and CEO Gareth Jenkins purchased a combined 185,758 ordinary shares on 21 August 2023. Each director acquired 92,879 shares at a price of 32.3 pence per share. Following these transactions, Dan Wright beneficially owns 12,608,422 shares, representing 3.95% of the issued share capital, and Gareth Jenkins beneficially owns 4,515,808 shares, representing 1.42%.
| Date | 22 Aug 2023 |
| Time | 07:00:06 |
| Category | Director/PDMR dealings |
| ID | 9930J |
22 August 2023
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.
Accrol Group Holdings plc
("Accrol", the "Group" or the "Company")
Director Dealings
Accrol (AIM:ACRL), the UK's leading independent tissue convertor, has been notified that Dan Wright, the Executive Chairman, and Gareth Jenkins, the Chief Executive Officer have purchased an aggregate of 185,758 ordinary shares of £0.001 each ("Ordinary Shares") at a price of 32.3 pence per Ordinary Share. Details of the dealings are included in the table below:
|
Director |
Ordinary Shares purchased |
Ordinary Shares beneficially owned |
% of issued share capital |
|
Dan Wright |
92,879 |
12,608,422* |
3.95% |
|
Gareth Jenkins |
92,879 |
4,515,808** |
1.42% |
* 10,786,972 of these shares are registered in the name of Gomrath Limited, a family investment company controlled by Dan Wright
** 3,741,346 of these shares are registered in the name of Gareth's wife Susan Jenkins
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
|
|
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a) |
Name |
Dan Wright |
||||
|
2 |
Reason for the notification |
|||||
|
a) |
Position/status |
Executive Chairman |
||||
|
b)
|
Initial notification /Amendment |
Initial notification |
||||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Accrol Group Holdings plc |
||||
|
b) |
LEI |
213800MC56M5G69RJ226 |
||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a)
|
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of £0.001 each
ISIN: GB00BZ6VT592 |
||||
|
b) |
Nature of the transaction |
Purchase of Ordinary Shares |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information - Aggregated volume - Price |
|
||||
|
e) |
Date of the transaction |
21 August 2023 |
||||
|
f) |
Place of the transaction |
London Stock Exchange, AIM |
||||
|
|
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a) |
Name |
Gareth Jenkins |
||||
|
2 |
Reason for the notification |
|||||
|
a) |
Position/status |
Chief Executive Officer |
||||
|
b)
|
Initial notification /Amendment |
Initial notification |
||||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Accrol Group Holdings plc |
||||
|
b) |
LEI |
213800MC56M5G69RJ226 |
||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a)
|
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of £0.001 each
ISIN: GB00BZ6VT592 |
||||
|
b) |
Nature of the transaction |
Purchase of Ordinary Shares |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information - Aggregated volume - Price |
|
||||
|
e) |
Date of the transaction |
21 August 2023 |
||||
|
f) |
Place of the transaction |
London Stock Exchange, AIM |
||||
|
For further information, please contact: |
|
|
|
|
|
Accrol Group Holdings plc |
|
|
Dan Wright, Executive Chairman |
Via Belvedere Communications |
|
Gareth Jenkins, Chief Executive Officer Richard Newman, Chief Financial Officer |
|
|
|
|
|
Zeus (Nominated Adviser & Joint Broker) |
|
|
Dan Bate / Jordan Warburton / Kieran Russell |
Tel: +44 (0) 161 831 1512 |
|
Dominic King |
Tel: +44 (0) 203 829 5000 |
|
|
|
|
Shore Capital Stockbrokers (Joint Broker) |
Tel: +44 (0) 20 7408 4090 |
|
Malachy McEntyre / Mark Percy / James Thomas |
|
|
|
|
|
Belvedere Communications Limited |
|
|
Cat Valentine |
Tel: +44 (0) 7715 769 078 |
|
Keeley Clarke |
Tel: +44 (0) 7967 816 525 |
|
|
Overview of Accrol
Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. The Group now operates from six manufacturing sites, including four in Lancashire, which together supply c.21.5% (volume) of the UK tissue market valued at c£2.5bn at retail sales value.
For more information, please visit www.accrol.com.